Reauthorise PEPFAR to prevent death, orphanhood, and suffering for millions of children

Since PEPFAR's implementation, AIDS deaths in infants and young children have fallen by 80% (figure D). PEPFAR's direct effects extend further to the reduction of subsequent negative outcomes on children's lives, such as avoidance of HIV-related developmental delays, family breakdown...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 2023-09, Vol.402 (10404), p.769-770
Main Authors: Cluver, Lucie, Imai-Eaton, Jeffrey W, Sherr, Lorraine, Mahy, Mary, Flaxman, Seth
Format: Article
Language:English
Subjects:
Acquired immune deficiency syndrome
AIDS
Antiretroviral agents
Antiretroviral drugs
Caregivers
Charities
Child abuse & neglect
Children
Children & youth
COVID-19
Disease transmission
Families & family life
Global health
HIV
Human immunodeficiency virus
Infections
Malaria
Medical research
Pediatrics
Poverty
Preventable deaths
Prevention
Public health
Reduction
Sexual behavior
Sexually transmitted diseases
STD
Tuberculosis
Vector-borne diseases
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Since PEPFAR's implementation, AIDS deaths in infants and young children have fallen by 80% (figure D). PEPFAR's direct effects extend further to the reduction of subsequent negative outcomes on children's lives, such as avoidance of HIV-related developmental delays, family breakdown and separation, abuse and mental health distress, and reduction of poverty-driven sexual exploitation of children. Abrupt halting of development aid can cause health system collapses.6 PEPFAR, the Global Fund to fight AIDS, Tuberculosis and Malaria, national governments, and donors such as the Bill & Melinda Gates Foundation are a crucial partnership for global health security.7 In 2022, PEPFAR provided life-saving antiretroviral medication to 20 million people8—most of them parents and children.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(23)01723-3